PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
02-Jun-2022 GlycoMimetics to Participate at Upcoming Jefferies 2022 Healthcare Conference Businesswire
02-Jun-2022 Immunicom Clinical Trial Data at ASCO 2022 Show Immunopheresis® LW-02 Column is Safe and Effectively Depletes Soluble TNF-α Receptors in Patients with Advanced Triple Negative Breast Cancer Businesswire
02-Jun-2022 Novotech Sponsors Pre-ASCO China Summit Panels on Early Phase Oncology Trials, Regulatory Strategy for China and US Novotech Health Holdings
02-Jun-2022 Worldwide Human Growth Hormone Treatment & Drugs Industry to 2032 - by Route of Administration, Application, Distribution Channel and Region - ResearchAndMarkets.com Businesswire
02-Jun-2022 Harris Williams Advises Dermatologists of Central States on its Partnership with SkyKnight Capital Businesswire
02-Jun-2022 5 For The Fight Announces New Class of Cancer Research Fellows Businesswire
02-Jun-2022 MaaT Pharma Confirms Positive Results from Completed Phase 1b CIMON Study Evaluating MaaT033 in Blood Cancer Patients Businesswire
02-Jun-2022 AmeriHealth Caritas Leaders Named to Modern Healthcare’s Top Diversity and Emerging Leaders Lists Businesswire
02-Jun-2022 Global Lymphedema Treatment Market (2022 to 2030) - Share, Size, Trends, Industry Analysis Report - ResearchAndMarkets.com Businesswire
02-Jun-2022 Audax Private Equity Announces Strategic Investment in Thermogenics Businesswire
02-Jun-2022 Alnylam Announces Publication of Preclinical Results Based on Novel Conjugate Technology That Facilitates Delivery of Short Interfering RNA to the Central Nervous System and Other Extrahepatic Tissues Businesswire
02-Jun-2022 Global Sodium Hyaluronate-based Products Market (2022 to 2030) - Share, Size, Trends, Industry Analysis Report - ResearchAndMarkets.com Businesswire
02-Jun-2022 Bristol Myers Squibb Announces Topline Results Showing Treatment with Orencia (abatacept) Improved Survival in People Hospitalized with COVID-19 Businesswire
02-Jun-2022 Proxygen Announces Strategic Collaboration with Merck to Develop Molecular Glue Degraders Businesswire
02-Jun-2022 Boehringer Ingelheim Enters Global Licensing Agreement to Develop and Commercialize Innovative Antibodies from A*STAR for Targeted Cancer Therapies Boehringer Ingelheim / A*STAR
02-Jun-2022 Dr. Jeffrey Kasher Joins Pro-Ficiency Board of Directors Newswire
02-Jun-2022 Vertex and CRISPR Therapeutics Announce Acceptance of Late-Breaking Abstract for CTX001™ at the 2022 Annual European Hematology Association (EHA) Congress Businesswire
02-Jun-2022 Global Additive Technology Markets for Engineered Solid Dosage Forms Report 2022 - ResearchAndMarkets.com Businesswire
02-Jun-2022 mAbxience Continues Manufacturing Capacity Expansion with ABEC Single-Use Bioreactor Technology Businesswire
02-Jun-2022 The Worldwide Diaphragm Pump Industry is Expected to Reach $7.3 Billion by 2027 - ResearchAndMarkets.com Businesswire